Investing Ideas
/
Swiss Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Swiss Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.

16 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
BANB Bachem Holding	CHF 56.10	-2.0%	0.7%	CHF 4.2b	CHF 76.86	PE37x	E17.8%	1.4%
KURN Kuros Biosciences	CHF 22.20	-11.6%	437.5%	CHF 840.3m	n/a	PS16x	n/a	n/a
COPN Cosmo Pharmaceuticals	CHF 63.80	-0.6%	4.9%	CHF 1.0b	CHF 98.37	PE15.6x	E21.5%	2.9%
MOLN Molecular Partners	CHF 4.75	4.4%	19.2%	CHF 174.9m	CHF 9.75	PS29.1x	E10.2%	n/a
SKAN SKAN Group	CHF 78.30	2.4%	-2.1%	CHF 1.8b	CHF 90.67	PE54.6x	E17.8%	0.4%
TECN Tecan Group	CHF 224.00	0.3%	-29.5%	CHF 2.9b	CHF 283.83	PE28.4x	E14.7%	1.3%
DESN Dottikon ES Holding	CHF 215.00	0%	2.1%	CHF 3.0b	CHF 350.00	PE39.3x	S16.4%	0%
BSLN Basilea Pharmaceutica	CHF 40.30	-4.3%	18.7%	CHF 488.5m	CHF 77.25	PS3.3x	E14.9%	0%
LONN Lonza Group	CHF 554.40	0.07%	53.4%	CHF 40.0b	CHF 638.15	PE69.9x	E21.0%	0.7%
ADXN Addex Therapeutics	CHF 0.061	-4.4%	15.5%	CHF 6.0m	CHF 0.16	PS10.2x	E18.5%	n/a
SANN Santhera Pharmaceuticals Holding	CHF 14.00	2.3%	40.0%	CHF 175.2m	CHF 25.00	PE2.8x	S-74.4%	n/a
RLF Relief Therapeutics Holding	CHF 3.90	1.3%	140.1%	CHF 48.9m	n/a	PS5.7x	n/a	n/a
PPGN PolyPeptide Group	CHF 24.35	-10.6%	71.6%	CHF 803.2m	CHF 34.72	PS2.6x	E64.9%	0%
NOVN Novartis	CHF 89.32	-1.9%	-4.8%	CHF 178.6b	CHF 103.51	PE16.6x	E7.0%	3.7%
GALD Galderma Group	CHF 108.70	0.2%	n/a	CHF 25.8b	CHF 101.82	PS6.5x	E36.4%	n/a
SFZN Siegfried Holding	CHF 983.00	-0.5%	15.4%	CHF 4.2b	CHF 1,167.67	PE32.7x	E13.0%	0.4%

Page 1 of 1